drugset / Trial / NCT05701540
A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study aims to compare the nighttime heartburn improvement effect of Tegoprazan 50mg and Esomeprazole 40mg(or 20mg) in patients with GERD.
Timeline
- Start
- 2023-03-24
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Esomeprazole | Small molecule | 20 mg | Oral |
| Comparator | Esomeprazole | Small molecule | 40 mg | Oral |
| Subject | Tegoprazan | Other / unclassified | 50 mg | Oral |